All-Wales Adult Asthma Management and Prescribing Guideline – ICST

All-Wales Adult Asthma Management and Prescribing Guideline

Developed by the Respiratory Health Implementation Group (RHIG), and endorsed by the All-Wales Medicines Strategy Group (AWMSG). The All-Wales Adult Asthma Management guideline standardises management of patients with Asthma. The aim of this Guideline is to provide patients with asthma with basic asthma care, in line with the Personal Asthma Action Plan, and monitor preventer and reliever inhaler prescribing.

 

Key Recommendations:

  • SABA monotherapy is not appropriate for the management of any patients with asthma
  • Use of reliever inhaler more than three times per week suggests poor asthma control
  • More than 6 SABA prescriptions per year, and less than 12 preventer inhalers should prompt urgent review

Related Education

The Asthma Annual Review

Which inhaler, for which patient?

Ongoing poor control

Achieving complete control

Starting treatment

Resources

Adult Asthma Pathway supporting notes

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk